Aug 08, 2024 / 09:00PM GMT
Operator
Thank you for standing by. My name is Rochelle, and I will be your conference operator today. At this time, I would like to welcome everyone to the OncoCyte second-quarter 2024 earnings conference call. (Operator Instructions)
I would now like to turn the call over to Jeff Ramson from PCG Advisory. Please go ahead.
Jeff Ramson - PCG Advisory Group - Investor Relations
Thank you, Rochelle, and thank you to everyone for joining us for today's conference call to discuss OncoCyte's second-quarter 2024 financial results and recent operating highlights. If you've not seen today's shareholder letter, please visit investors.oncocyte.com to read it. Today's prepared remarks build upon the information already shared in this robust letter.
Before turning the call over to OncoCyte President and CEO, Josh Riggs, I'd like to go over our Safe Harbor statement. The company will make projections and forward-looking statements regarding future events. Any statements that are not historical facts are forward-looking statements.
These statements are
Q2 2024 OncoCyte Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
